Document Detail


Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study.
MedLine Citation:
PMID:  23617861     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVES: A paucity of studies has examined the pain experiences of opioid dependent individuals seeking office-based buprenorphine-naloxone treatment (BNT). We set out to examine, among those seeking BNT: (a) the prevalence of pain types (i.e., recent pain, chronic pain), (b) the characteristics of pain (intensity, frequency, duration, interference, location, and genesis), and (c) substance use to alleviate pain.
METHOD: We surveyed 244 consecutive individuals seeking office-based BNT for opioid dependence about physical pain and associated substance use.
RESULTS: Thirty-six percent of respondents reported chronic pain (CP) (i.e., pain lasting at least 3 months) and 36% reported "some pain" (SP) (i.e., past week pain not meeting the threshold for CP). In comparison to SP respondents, those with CP were, on average, older; reported greater current pain intensity, pain frequency, typical pain duration, typical pain intensity, and typical pain interference; were more likely to report shoulder or pelvis and less likely to report stomach or arms as their most bothersome pain location; and were more likely to report accident or nerve damage and less likely to report opioid withdrawal as the genesis of their pain. Both pain subgroups reported similarly high rates of past-week substance use to alleviate pain.
CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: The high rates of pain and self-reported substance use to manage pain suggest the importance of assessing and addressing pain in BNT patients.
Authors:
Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions     Volume:  22     ISSN:  1521-0391     ISO Abbreviation:  Am J Addict     Publication Date:    2013 May-Jun
Date Detail:
Created Date:  2013-04-26     Completed Date:  2013-10-29     Revised Date:  2014-05-07    
Medline Journal Info:
Nlm Unique ID:  9208821     Medline TA:  Am J Addict     Country:  England    
Other Details:
Languages:  eng     Pagination:  212-7     Citation Subset:  IM    
Copyright Information:
Copyright © American Academy of Addiction Psychiatry.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Analgesics, Opioid / therapeutic use*
Buprenorphine / therapeutic use*
Female
Humans
Male
Middle Aged
Naloxone / therapeutic use*
Narcotic Antagonists / therapeutic use*
Needs Assessment
Opiate Substitution Treatment
Opioid-Related Disorders / drug therapy*
Pain / classification*,  drug therapy,  etiology
Prescription Drug Misuse
Prevalence
Street Drugs
Grant Support
ID/Acronym/Agency:
K01 DA022398/DA/NIDA NIH HHS; K01 DA022398/DA/NIDA NIH HHS; K23 DA024050/DA/NIDA NIH HHS; K23 DA024050/DA/NIDA NIH HHS; K24 DA000445/DA/NIDA NIH HHS; K24 DA000445/DA/NIDA NIH HHS; P30 MH062294/MH/NIMH NIH HHS; R01 DA019511/DA/NIDA NIH HHS; R01 DA019511/DA/NIDA NIH HHS; R01 DA020576/DA/NIDA NIH HHS; R01 DA020576/DA/NIDA NIH HHS; R01 DA024695/DA/NIDA NIH HHS; R01DA024695/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Analgesics, Opioid; 0/Narcotic Antagonists; 0/Street Drugs; 36B82AMQ7N/Naloxone; 40D3SCR4GZ/Buprenorphine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An analysis of relapse prevention factors and their ability to predict sustained abstinence followin...
Next Document:  Pathological and Problem Gambling among Veterans in Clinical Care: Prevalence, Demography, and Clini...